Literature DB >> 26961355

Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.

Marilena Hadjidemetriou1, Zahraa Al-Ahmady, Kostas Kostarelos.   

Abstract

Nanoparticles (NPs) are instantly modified once injected in the bloodstream because of their interaction with the blood components. The spontaneous coating of NPs by proteins, once in contact with biological fluids, has been termed the 'protein corona' and it is considered to be a determinant factor for the pharmacological, toxicological and therapeutic profile of NPs. Protein exposure time is thought to greatly influence the composition of protein corona, however the dynamics of protein interactions under realistic, in vivo conditions remain unexplored. The aim of this study was to quantitatively and qualitatively investigate the time evolution of in vivo protein corona, formed onto blood circulating, clinically used, PEGylated liposomal doxorubicin. Protein adsorption profiles were determined 10 min, 1 h and 3 h post-injection of liposomes into CD-1 mice. The results demonstrated that a complex protein corona was formed as early as 10 min post-injection. Even though the total amount of protein adsorbed did not significantly change over time, the fluctuation of protein abundances observed indicated highly dynamic protein binding kinetics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26961355     DOI: 10.1039/c5nr09158f

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  29 in total

Review 1.  The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.

Authors:  John L Brash; Thomas A Horbett; Robert A Latour; Pentti Tengvall
Journal:  Acta Biomater       Date:  2019-06-18       Impact factor: 8.947

Review 2.  Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products.

Authors:  Jessie L-S Au; Ze Lu; Roberto A Abbiati; M Guillaume Wientjes
Journal:  AAPS J       Date:  2019-02-01       Impact factor: 4.009

3.  Global diffusion limitations during the initial phase of the formation of a protein corona around nanoparticles.

Authors:  Vladimir P Zhdanov
Journal:  J Biol Phys       Date:  2019-03-20       Impact factor: 1.365

4.  Nanomedicine: Evolution of the nanoparticle corona.

Authors:  Marilena Hadjidemetriou; Kostas Kostarelos
Journal:  Nat Nanotechnol       Date:  2017-04-06       Impact factor: 39.213

Review 5.  Target Site Delivery and Residence of Nanomedicines: Application of Quantitative Systems Pharmacology.

Authors:  Jessie L-S Au; Roberto A Abbiati; M Guillaume Wientjes; Ze Lu
Journal:  Pharmacol Rev       Date:  2019-04       Impact factor: 25.468

Review 6.  Analysing the nanoparticle-protein corona for potential molecular target identification.

Authors:  Chandra Kumar Elechalawar; Md Nazir Hossen; Lacey McNally; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  J Control Release       Date:  2020-03-09       Impact factor: 9.776

7.  Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer's Disease.

Authors:  Marilena Hadjidemetriou; Jack Rivers-Auty; Lana Papafilippou; James Eales; Katherine A B Kellett; Nigel M Hooper; Catherine B Lawrence; Kostas Kostarelos
Journal:  ACS Nano       Date:  2021-03-17       Impact factor: 15.881

8.  Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona.

Authors:  Klemen Strojan; Adrijana Leonardi; Vladimir B Bregar; Igor Križaj; Jurij Svete; Mojca Pavlin
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

Review 9.  Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment.

Authors:  Stuart P Atkinson; Zoraida Andreu; María J Vicent
Journal:  J Pers Med       Date:  2018-01-23

10.  Triphenyl Phosphine-Functionalized Chitosan Nanoparticles Enhanced Antitumor Efficiency Through Targeted Delivery of Doxorubicin to Mitochondria.

Authors:  Jiahui Hou; Xiwei Yu; Yaping Shen; Yijie Shi; Chang Su; Liang Zhao
Journal:  Nanoscale Res Lett       Date:  2017-02-28       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.